Real-time enrollment status for this uterine sarcoma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:40 PM UTC
| NCT Number | NCT07467772 |
| Recruiting Status | Recruiting |
| Condition | Uterine Sarcoma |
| Phase | PHASE2 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of August 27, 2026: Clinical trial NCT07467772 is currently recruiting participants. This phase2 study for uterine sarcoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07467772 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07467772 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.